Invasight
company
About
Invasight is a clinical biotech company that focused on revolutionizing cell invasion research.
- 1 - 10
Details
- Last Funding Type
- Seed
- Last Funding Money Raised
- Fr4.50M
- Industries
- Biopharma,Biotechnology,Health Care
- Founded date
- Jan 1, 2019
- Number Of Employee
- 1 - 10
- Operating Status
- Active
Invasight is a clinical biotech company that focused on revolutionizing cell invasion research.
The company was founded in 2019 and is headquartered in Zurich, Switzerland.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
Fr4.50M
Invasight has raised a total of
Fr4.50M
in funding over 2 rounds. Their latest funding was raised on
Jun 7, 2022 from a Seed round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Jun 7, 2022 | Seed | Fr4.50M | 2 |
|
— | Detail |
Investors
Number of Lead Investors
Number of Investors
1
2
Invasight is funded by 2 investors.
JFG Life Sciences Foundation
and Verve Ventures
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
|
Yes | Seed |
Verve Ventures
|
— | Seed |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
